Motley Fool Wealth Management LLC Has $12.89 Million Stock Holdings in Waters Corporation (NYSE:WAT)

Motley Fool Wealth Management LLC decreased its stake in Waters Corporation (NYSE:WAT) by 9.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,970 shares of the medical instruments supplier’s stock after selling 3,505 shares during the period. Motley Fool Wealth Management LLC’s holdings in Waters were worth $12,889,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Lederer & Associates Investment Counsel CA boosted its holdings in Waters by 1.0% in the first quarter. Lederer & Associates Investment Counsel CA now owns 3,155 shares of the medical instruments supplier’s stock worth $1,163,000 after acquiring an additional 30 shares in the last quarter. FourThought Financial Partners LLC boosted its holdings in Waters by 5.1% in the first quarter. FourThought Financial Partners LLC now owns 658 shares of the medical instruments supplier’s stock worth $243,000 after acquiring an additional 32 shares in the last quarter. Benjamin Edwards Inc. boosted its holdings in Waters by 4.8% in the fourth quarter. Benjamin Edwards Inc. now owns 744 shares of the medical instruments supplier’s stock worth $276,000 after acquiring an additional 34 shares in the last quarter. Claret Asset Management Corp boosted its holdings in Waters by 3.6% in the fourth quarter. Claret Asset Management Corp now owns 1,103 shares of the medical instruments supplier’s stock worth $409,000 after acquiring an additional 38 shares in the last quarter. Finally, Lido Advisors LLC boosted its holdings in Waters by 2.2% in the fourth quarter. Lido Advisors LLC now owns 1,734 shares of the medical instruments supplier’s stock worth $643,000 after acquiring an additional 38 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Performance

Shares of Waters stock opened at $280.96 on Monday. The business’s fifty day simple moving average is $325.40 and its 200 day simple moving average is $349.97. The firm has a market capitalization of $16.72 billion, a P/E ratio of 25.33, a price-to-earnings-growth ratio of 2.62 and a beta of 1.04. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55.

Waters (NYSE:WAT) last issued its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, topping analysts’ consensus estimates of $2.93 by $0.02. The business had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%. Waters’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period last year, the company posted $2.63 earnings per share. As a group, analysts anticipate that Waters Corporation will post 12.86 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. UBS Group reiterated a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Wells Fargo & Company dropped their target price on Waters from $330.00 to $315.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 5th. Deutsche Bank Aktiengesellschaft dropped their target price on Waters from $375.00 to $315.00 and set a “hold” rating on the stock in a report on Tuesday, August 5th. Scotiabank restated a “sector outperform” rating and issued a $465.00 target price on shares of Waters in a report on Friday, July 11th. Finally, Robert W. Baird dropped their target price on Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a report on Wednesday, July 16th. Ten equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $378.73.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.